Aftab Ala

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites

Aftab Ala, Carmen Stanca, Moueen Bu-Ghanim et al. · Hepatology · 2006 · 226 citations

Medicine, Pathology, Gastroenterology +10

Wilson disease in septuagenarian siblings

Aftab Ala, Jimo Borjigin, Arnold Rochwarger et al. · Hepatology · 2005 · 209 citations

Medicine, Molecular Genetics, Molecular Medicine +17

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

Karl Heinz Weiss, Frederick K. Askari, Anna Członkowska et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 169 citations

Medicine, Neurology, Pharmacotherapy +6

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 163 citations · Full text

Medicine, Internal Medicine, Hepatology +9